EATRIS

Research Services • Amsterdam, North Holland, Netherlands • 51-100 Employees

Company overview

Headquarters	De Boelelaan 1118, Amsterdam, Noord Holland 1081 HZ, NL
Phone number	+31204442254
Website	eatris.eu
NAICS	5417
SIC	873
Keywords	Matchmaking, Biomarkers, Education And Training, Translational Medicine, Small Molecules, Regulatory Advice, Vaccines, Atmp, Research Infrastructures, Imaging And Tracing
Employees	51-100
Socials

Key Contacts at EATRIS

Marian Hajduch

National Director Of Eatris-Eric For The Czech Republic

Anton Ussi

Operations & Finance Director Ceo

Toni Andreu

Scientific Director

Florence Bietrix

Deputy Director

EATRIS Email Formats

EATRIS uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@eatris.eu), used 50% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@eatris.eu	50%
{first name}{last name}	johndoe@eatris.eu	46.7%
{first initial}{first initial}	jj@eatris.eu	3.3%

About EATRIS

EATRIS is the European infrastructure for translational medicine. We bring together resources and services for research communities to translate scientific discoveries into benefits for patients. We provide access to a vast array of pre-clinical and clinical expertise and facilities that are available within 115+ top-tier academic centres across Europe. We focus on improving and optimising preclinical and early clinical development of drugs, vaccines and diagnostics, and overcome barriers to health innovation. Our research infrastructure offers a broad range of research services for both academia and industry across various research fields. In addition, we work with public funding agencies, charities and policy makers with tailored actions to help improve the translational research and innovation ecosystem.

EATRIS revenue & valuation

Annual revenue	$4,363,305
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues	$14,000,000
Total funding	No funding